These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35187881)

  • 1. Improving siRNA design targeting nucleoprotein gene as antiviral against the Indonesian H5N1 virus.
    Hartawan R; Pujianto DA; Dharmayanti NLPI; Soebandrio A
    J Vet Sci; 2022 Mar; 23(2):e24. PubMed ID: 35187881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient Inhibition of Avian and Seasonal Influenza A Viruses by a Virus-Specific Dicer-Substrate Small Interfering RNA Swarm in Human Monocyte-Derived Macrophages and Dendritic Cells.
    Jiang M; Österlund P; Westenius V; Guo D; Poranen MM; Bamford DH; Julkunen I
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30463970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of influenza virus siRNA expression vectors and their inhibitory effects on multiplication of influenza virus.
    Li YC; Kong LH; Cheng BZ; Li KS
    Avian Dis; 2005 Dec; 49(4):562-73. PubMed ID: 16405000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice.
    Zhou H; Jin M; Yu Z; Xu X; Peng Y; Wu H; Liu J; Liu H; Cao S; Chen H
    Antiviral Res; 2007 Nov; 76(2):186-93. PubMed ID: 17719657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral Determinants in H5N1 Influenza A Virus Enable Productive Infection of HeLa Cells.
    Rodriguez-Frandsen A; Martin-Sancho L; Gounder AP; Chang MW; Liu WC; De Jesus PD; von Recum-Knepper J; Dutra MS; Huffmaster NJ; Chavarria M; Mena I; Riva L; Nguyen CB; Dobariya S; Herbert KM; Benner C; Albrecht RA; García-Sastre A; Chanda SK
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31776276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. siRNAs targeting PB2 and NP genes potentially inhibit replication of Highly Pathogenic H5N1 Avian Influenza Virus.
    Behera P; Nagarajan S; Murugkar HV; Kalaiyarasu S; Prakash A; Gothalwal R; Dubey SC; Kulkarni DD; Tosh C
    J Biosci; 2015 Jun; 40(2):233-40. PubMed ID: 25963253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted small interfering RNA-immunoliposomes as a promising therapeutic agent against highly pathogenic Avian Influenza A (H5N1) virus infection.
    Khantasup K; Kopermsub P; Chaichoun K; Dharakul T
    Antimicrob Agents Chemother; 2014 May; 58(5):2816-24. PubMed ID: 24614365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine efficacy against Indonesian Highly Pathogenic Avian Influenza H5N1: systematic review and meta-analysis.
    Villanueva-Cabezas JP; Coppo MJC; Durr PA; McVernon J
    Vaccine; 2017 Sep; 35(37):4859-4869. PubMed ID: 28780119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of highly pathogenic avian influenza A(H5N1) viruses in Indonesia following the reassortment and acquisition of genes from low pathogenicity avian influenza A virus progenitors.
    Dharmayanti NLPI; Thor SW; Zanders N; Hartawan R; Ratnawati A; Jang Y; Rodriguez M; Suarez DL; Samaan G; Pudjiatmoko ; Davis CT
    Emerg Microbes Infect; 2018 Aug; 7(1):147. PubMed ID: 30131494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral Factors Associated With the High Mortality Related to Human Infections With Clade 2.1 Influenza A/H5N1 Virus in Indonesia.
    Pawestri HA; Eggink D; Isfandari S; Thanh TT; Rogier van Doorn H; Setiawaty V; de Jong MD
    Clin Infect Dis; 2020 Mar; 70(6):1139-1146. PubMed ID: 31321436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of high and low pathogenic avian influenza virus H5 subtypes by copper ions incorporated in zeolite-textile materials.
    Imai K; Ogawa H; Bui VN; Inoue H; Fukuda J; Ohba M; Yamamoto Y; Nakamura K
    Antiviral Res; 2012 Feb; 93(2):225-233. PubMed ID: 22179064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.
    Swayne DE; Suarez DL; Spackman E; Jadhao S; Dauphin G; Kim-Torchetti M; McGrane J; Weaver J; Daniels P; Wong F; Selleck P; Wiyono A; Indriani R; Yupiana Y; Sawitri Siregar E; Prajitno T; Smith D; Fouchier R
    J Virol; 2015 Apr; 89(7):3746-62. PubMed ID: 25609805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized clade 2.3.2.1c H5N1 recombinant-vaccine strains against highly pathogenic avian influenza.
    Jang JW; Lee CY; Kim IH; Choi JG; Lee YJ; Yuk SS; Lee JH; Song CS; Kim JH; Kwon HJ
    J Vet Sci; 2017 Aug; 18(S1):299-306. PubMed ID: 28859269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and antigenic characterization of influenza A/H5N1 viruses isolated from patients in Indonesia, 2008-2015.
    Pawestri HA; Nugraha AA; Han AX; Pratiwi E; Parker E; Richard M; van der Vliet S; Fouchier RAM; Muljono DH; de Jong MD; Setiawaty V; Eggink D
    Virus Genes; 2020 Aug; 56(4):417-429. PubMed ID: 32483655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A two dose immunization with an inactivated reassortant H5N2 virus protects chickens against lethal challenge with homologous 2.3.2.1 clade and heterologous 2.2 clade highly pathogenic avian influenza H5N1 viruses.
    Bhat S; Sood R; Shukla S; Khandia R; Pateriya AK; Kumar N; Singh VK; Kalaiyarasu S; Kumar M; Bhatia S
    Vet Microbiol; 2018 Apr; 217():149-157. PubMed ID: 29615248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PB2 Polymerase Host Adaptation Substitutions Prime Avian Indonesia Sub Clade 2.1 H5N1 Viruses for Infecting Humans.
    Wang P; Song W; Mok BW; Zheng M; Lau SY; Liu S; Chen P; Huang X; Liu H; Cremin CJ; Chen H
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30909490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA interference of avian influenza virus H5N1 by inhibiting viral mRNA with siRNA expression plasmids.
    Zhou K; He H; Wu Y; Duan M
    J Biotechnol; 2008 Jun; 135(2):140-4. PubMed ID: 18456361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense oligonucleotides targeting the RNA binding region of the NP gene inhibit replication of highly pathogenic avian influenza virus H5N1.
    Zhang T; Wang TC; Zhao PS; Liang M; Gao YW; Yang ST; Qin C; Wang CY; Xia XZ
    Int Immunopharmacol; 2011 Dec; 11(12):2057-61. PubMed ID: 21933722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic Effects of Substitutions within the Receptor Binding Site of Highly Pathogenic Avian Influenza H5N1 Virus Observed during Human Infection.
    Eggink D; Spronken M; van der Woude R; Buzink J; Broszeit F; McBride R; Pawestri HA; Setiawaty V; Paulson JC; Boons GJ; Fouchier RAM; Russell CA; de Jong MD; de Vries RP
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of M2e ELISAs for longitudinal surveillance of commercial poultry in Indonesia vaccinated against highly pathogenic avian influenza.
    Wibowo MH; Tarigan S; Sumarningsih ; Artanto S; Indriani R; Anggoro D; Putra CP; Idris S; Untari T; Asmara W; Tabbu CR; Ignjatovic J
    J Virol Methods; 2017 Nov; 249():181-188. PubMed ID: 28843786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.